chiara.nicolazzo@uniroma1.it's picture
Title Journal Year
True conversions from RAS mutant to RAS wild-type in circulating tumor DNA from metastatic colorectal cancer patients as assessed by methylation and mutational signature CANCER LETTERS 2021
Detection of circulating tumor cells in patients with laryngeal cancer using screencell: comparative pre- and post-operative analysis and association with prognosis ONCOLOGY LETTERS 2020
Molecular Biomarkers according to Primary Tumor Location in Colorectal Cancer: Current Standard and New Insights ONCOLOGY 2020
Baseline CD44v6-positive circulating tumor cells to predict first-line treatment failure in patients with metastatic colorectal cancer ONCOTARGET 2020
Liquid Biopsy for Predicting Bacillus Calmette-Guérin Unresponsiveness in Non-muscle-invasive Bladder Cancer EUROPEAN UROLOGY ONCOLOGY 2020
Circulating methylated DNA to monitor the dynamics of RAS mutation clearance in plasma from metastatic colorectal cancer patients CANCERS 2020
Transient disappearance of RAS mutant clones in plasma: A counterintuitive clinical use of EGFR inhibitors in RAS mutant metastatic colorectal cancer CANCERS 2019
Circulating Tumor Cells Identify Patients with Super-High-Risk Non-Muscle-Invasive Bladder Cancer: Updated Outcome Analysis of a Prospective Single-Center Trial THE ONCOLOGIST 2019
Improving the Nuclear-Localized Androgen Receptor Splice Variant 7 Test JAMA ONCOLOGY 2019
Molecular Characterization of Circulating Tumor Cells to Study Cancer Immunoevasion 2019
Circulating tumor cells in right-and left-sided colorectal cancer CANCERS 2019
EpCAMlow circulating tumor cells: Gold in the waste DISEASE MARKERS 2019
Why the Therapeutic Impact of RAS Mutation Clearance in Plasma ctDNA Deserves to Be Further Explored in Metastatic Colorectal Cancer FRONTIERS IN ONCOLOGY 2019
Improving the Nuclear-Localized Androgen Receptor Splice Variant 7 Test JAMA ONCOLOGY 2019
Liquid Biopsy in Rare Cancers: Lessons from Hemangiopericytoma ANALYTICAL CELLULAR PATHOLOGY 2018
Circulating tumor cells: from fiction to reality CLINICS IN ONCOLOGY 2018
Coexistence of three EGFR mutations in an NSCLC patient: A brief report THE INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS 2018
EpCAM expressing circulating tumor cells in colorectal cancer THE INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS 2017
The long-term prognostic value of survivin expressing circulating tumor cells in patients with high-risk non-muscle invasive bladder cancer (NMIBC) JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY 2017
PD-L1 and epithelial-mesenchymal transition in circulating tumor cells from non-small cell lung cancer patients: a molecular shield to evade immune system? ONCOIMMUNOLOGY 2017